Genomics plc selected by Innovate UK as an example of a grant recipient success story.

Watch Peter Donnelly’s keynote address at ICML, 2017.

Genomics’ Proprietary Statistical Analysis Tools and Integrated Multi-Phenotype Database to be used to Support Research and Development at Vertex Pharmaceuticals.

Genomics plc has entered into a collaboration agreement with Biogen. The collaboration aims to refine drug target selection through the use of sophisticated analysis of human genetic data.

Eisai and Genomics plc today announce a collaborative agreement to use Genomics’ sophisticated statistical analyses of large-scale multi-phenotype genetic association data to inform Eisai’s drug discovery process.

Nature article: History revealed in Britain’s genes.

Genomics has secured £2m to develop its genome analysis platform in a Small Business Research Initiative (SBRI) competition.

Genomics plc selected by Innovate UK as an example of a grant recipient success story.

Watch Peter Donnelly’s keynote address at ICML, 2017.

Genomics’ Proprietary Statistical Analysis Tools and Integrated Multi-Phenotype Database to be used to Support Research and Development at Vertex Pharmaceuticals.

Genomics plc has entered into a collaboration agreement with Biogen. The collaboration aims to refine drug target selection through the use of sophisticated analysis of human genetic data.

Eisai and Genomics plc today announce a collaborative agreement to use Genomics’ sophisticated statistical analyses of large-scale multi-phenotype genetic association data to inform Eisai’s drug discovery process.

Nature article: History revealed in Britain’s genes.

Genomics has secured £2m to develop its genome analysis platform in a Small Business Research Initiative (SBRI) competition.

Genomics plc selected by Innovate UK as an example of a grant recipient success story.

Watch Peter Donnelly’s keynote address at ICML, 2017.

Genomics’ Proprietary Statistical Analysis Tools and Integrated Multi-Phenotype Database to be used to Support Research and Development at Vertex Pharmaceuticals.

Genomics plc has entered into a collaboration agreement with Biogen. The collaboration aims to refine drug target selection through the use of sophisticated analysis of human genetic data.

Eisai and Genomics plc today announce a collaborative agreement to use Genomics’ sophisticated statistical analyses of large-scale multi-phenotype genetic association data to inform Eisai’s drug discovery process.

Nature article: History revealed in Britain’s genes.

Genomics has secured £2m to develop its genome analysis platform in a Small Business Research Initiative (SBRI) competition.